These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9619912)

  • 61. Late mortality after bone marrow transplant for chronic myelogenous leukemia in the context of prior tyrosine kinase inhibitor exposure: A Blood or Marrow Transplant Survivor Study (BMTSS) report.
    Wu J; Chen Y; Hageman L; Francisco L; Ness EC; Parman M; Kung M; Watson JA; Weisdorf DJ; Snyder DS; McGlave PB; Forman SJ; Arora M; Armenian SH; Bhatia R; Bhatia S
    Cancer; 2019 Nov; 125(22):4033-4042. PubMed ID: 31412155
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Eosinophilia after allogeneic bone marrow transplantation using the busulfan and cyclophosphamide preparative regimen.
    Kalaycioglu ME; Bolwell BJ
    Bone Marrow Transplant; 1994 Jul; 14(1):113-5. PubMed ID: 7951097
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Total body irradiation correlates with chronic graft versus host disease and affects prognosis of patients with acute lymphoblastic leukemia receiving an HLA identical allogeneic bone marrow transplant.
    Corvò R; Paoli G; Barra S; Bacigalupo A; Van Lint MT; Franzone P; Frassoni F; Scarpati D; Bacigalupo A; Vitale V
    Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):497-503. PubMed ID: 10078628
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Ringdén O; Labopin M; Tura S; Arcese W; Iriondo A; Zittoun R; Sierra J; Gorin NC
    Br J Haematol; 1996 Jun; 93(3):637-45. PubMed ID: 8652385
    [TBL] [Abstract][Full Text] [Related]  

  • 65. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).
    Frassoni F; Labopin M; Gluckman E; Prentice HG; Vernant JP; Zwaan F; Granena A; Gahrton G; De Witte T; Gratwohl A; Reiffers J; Gorin NC
    Bone Marrow Transplant; 1996 Jan; 17(1):13-8. PubMed ID: 8673048
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Therapeutic trial of intensified conditioning regimen with high-dose cytosine arabinoside, cyclophosphamide and either total body irradiation or busulfan followed by allogeneic bone marrow transplantation for myelodysplastic syndrome in children.
    Nagatoshi Y; Okamura J; Ikuno Y; Akamatsu M; Tasaka H
    Int J Hematol; 1997 Apr; 65(3):269-75. PubMed ID: 9114598
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Long-term outcome after allogeneic bone marrow transplantation for hematological malignancies with non-remission status. Results of a single-center study of 24 patients.
    Tabata M; Satake A; Okura N; Yamazaki Y; Toda A; Nishioka K; Tanaka H; Chin M; Itsukuma T; Yamaguchi M; Misawa M; Kai S; Hara H
    Ann Hematol; 2002 Oct; 81(10):582-7. PubMed ID: 12424540
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide.
    Bostrom B; Weisdorf DJ; Kim T; Kersey JH; Ramsay NK
    Bone Marrow Transplant; 1990 Feb; 5(2):83-9. PubMed ID: 2107007
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cytogenetic correlation with disease status and treatment outcome in advanced stage leukemia post bone marrow transplantation: a Southwest Oncology Group study (SWOG-8612).
    Slovak ML; Kopecky KJ; Wolman SR; Henslee-Downey JP; Appelbaum FR; Forman SJ; Blume KG
    Leuk Res; 1995 Jun; 19(6):381-8. PubMed ID: 7596150
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Autologous bone marrow transplantation for haematological malignancies--experiences of the centre of Zagreb.
    Nemet D; Labar B; Bogdanic V; Skodlar J; Petrovecki M; Mrsic M; Maravic N; Sneller V; Radman I; Kovacevic-Metelko J
    Wien Med Wochenschr; 1995; 145(2-3):61-4. PubMed ID: 7762256
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
    Gallardo D; García-López J; Sureda A; Canals C; Ferra C; Cancelas JA; Berlanga JJ; Brunet S; Boqué C; Picón M; Torrico C; Amill B; Martino R; Martínez C; Martín-Henao G; Domingo-Albós A; Grañena A
    Bone Marrow Transplant; 1997 Dec; 20(11):945-52. PubMed ID: 9422473
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemotherapy: a Société Française de Greffe de Moelle study.
    Bordigoni P; Esperou H; Souillet G; Pico J; Michel G; Lacour B; Reiffers J; Sadoun A; Rohrlich P; Jouet JP; Milpied N; Lutz P; Plouvier E; Cornu G; Vannier JP; Gandemer V; Rubie H; Gratecos N; Leverger G; Stephan JL; Boutard P; Vernant JP
    Br J Haematol; 1998 Aug; 102(3):656-65. PubMed ID: 9722290
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Increased risk of severe acute graft-versus-host disease in low body mass index patients undergoing haploidentical allogeneic stem cell transplantation].
    Chen Y; Xu L; Liu D; Liu K; Chen H; Zhang X; Wang F; Wang J; Wang Y; Han W; Chen Y; Yan C; Zhao T; Huang X
    Zhonghua Nei Ke Za Zhi; 2014 Sep; 53(9):710-4. PubMed ID: 25511404
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Growth in children after bone marrow transplantation.
    Bozzola M; Giorgiani G; Locatelli F; Cisternino M; Gambarana D; Zecca M; Torcetta F; Severi F
    Horm Res; 1993; 39(3-4):122-6. PubMed ID: 8262472
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Treatment of chronic myelomonocytic leukaemia by allogeneic marrow transplantation.
    Zang DY; Deeg HJ; Gooley T; Anderson JE; Anasetti C; Sanders J; Myerson D; Storb R; Appelbaum F
    Br J Haematol; 2000 Jul; 110(1):217-22. PubMed ID: 10931002
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Late effects of chemotherapy compared to bone marrow transplantation in the treatment of pediatric acute myeloid leukemia and myelodysplasia.
    Leahey AM; Teunissen H; Friedman DL; Moshang T; Lange BJ; Meadows AT
    Med Pediatr Oncol; 1999 Mar; 32(3):163-9. PubMed ID: 10064182
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Reduction of graft failure by a monoclonal antibody (anti-LFA-1 CD11a) after HLA nonidentical bone marrow transplantation in children with immunodeficiencies, osteopetrosis, and Fanconi's anemia: a European Group for Immunodeficiency/European Group for Bone Marrow Transplantation report.
    Fischer A; Friedrich W; Fasth A; Blanche S; Le Deist F; Girault D; Veber F; Vossen J; Lopez M; Griscelli C
    Blood; 1991 Jan; 77(2):249-56. PubMed ID: 1985691
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Phase I trial of interleukin-2 after unmodified HLA-matched sibling bone marrow transplantation for children with acute leukemia.
    Robinson N; Sanders JE; Benyunes MC; Beach K; Lindgren C; Thompson JA; Appelbaum FR; Fefer A
    Blood; 1996 Feb; 87(4):1249-54. PubMed ID: 8608212
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Bone marrow transplantation for treatment of chronic myelogenous leukaemia (CML)--preliminary experience in Singapore.
    Ong YW; Tan P; Lim SH; Ng HW; Goh YT
    Ann Acad Med Singap; 1990 Mar; 19(2):169-74. PubMed ID: 2346290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.